
Vinyl chloroacetate | CAS:2549-51-1
Vinyl chloroacetate
- 名称:氯乙酸乙烯酯; 氯代醋酸乙烯酯 | Vinyl chloroacetate
- CAS号:2549-51-1
- 别名:Chloroacetic acid vinyl ester
- 分子式:C4H5ClO2
- 分子量:120.53
- EINESC号:219-834-3
产品描述
物理化学性质
闪点 | 51 ºC |
---|---|
密度 | 1.192 |
折射率 | 1.444 |
安全数据
危险品标志 | C |
---|---|
危险类别码 | R10;R20/21/22;R34 |
安全说明书 | S26;S36/37/39;S45 |
产品合成路线
名称 | CAS号 |
---|
更多
文章
同行评议文献
[Effect of the energy metabolism regulator Yantar-Antitox on the system of energy production in rat liver during experimental pathology of beta-oxidation].A V Chernikov et al.Eksperimental'naia i klinicheskaia farmakologiia, 75(5), 24-27 (2012-07-28)
Surface Eroding, Semicrystalline Polyanhydrides via Thiol-Ene "Click" Photopolymerization.Katie L Poetz et al.Biomacromolecules, 16(5), 1650-1659 (2015-04-14)
Diglucosyl-glycerolipids from the marine sponge-associated Bacillus pumilus strain AAS3: their production, enzymatic modification and properties.W Ramm et al.Applied microbiology and biotechnology, 64(4), 497-504 (2003-11-01)
Hyperpolarization of the cell membrane of mouse hepatocytes by fatty acid oxidation.R Rossi et al.Physiology & behavior, 57(3), 509-514 (1995-03-01)
Alternative pig liver esterase (APLE) - cloning, identification and functional expression in Pichia pastoris of a versatile new biocatalyst.Manuela Hermann et al.Journal of biotechnology, 133(3), 301-310 (2007-12-15)
Communication: Light driven remote control of microgels' size in the presence of photosensitive surfactant: Complete phase diagram.Selina Schimka et al.The Journal of chemical physics, 147(3), 031101-031101 (2017-07-25)
Heterogeneous metabolism and toxicity of 4-pentenoate along the dog nephron.Y Boulanger et al.Renal physiology and biochemistry, 16(4), 182-202 (1993-07-01)
An organocatalytic asymmetric chlorolactonization.Daniel C Whitehead et al.Journal of the American Chemical Society, 132(10), 3298-3300 (2010-02-23)
Induction of the mitochondrial permeability transition in vitro by short-chain carboxylic acids.C M Palmeira et al.Biochemical and biophysical research communications, 272(2), 431-435 (2000-06-02)
On the rate-determining step of fatty acid oxidation in heart. Inhibition of fatty acid oxidation by 4-pentenoic acid.J C Fong et al.The Journal of biological chemistry, 253(19), 6917-6922 (1978-10-10)
Bile acid-based cage compounds with lipophilic outer shells and inner cavities.Xinyan Bai et al.Organic letters, 13(12), 3064-3067 (2011-05-20)
Resveratrol protects against experimental induced Reye's syndrome by prohibition of oxidative stress and restoration of complex I activity.Amany Abdin et al.Canadian journal of physiology and pharmacology, 92(9), 780-788 (2014-08-28)
Rec. Trav. Chim., 111, 478-478 (1992)
Effects of pentanoate, 4-pentenoate, 3-hydroxybutyrate and insulin on the tissue-levels of long-chain acyl CoA and acylcarnitine in the oxygenated and hypoxic rat atria.A Varela et al.Archives of physiology and biochemistry, 107(1), 22-26 (1999-08-24)
Pentenoic acid pathways for cellulosic biofuels.Regina Palkovits Angewandte Chemie (International ed. in English), 49(26), 4336-4338 (2010-05-19)
[Effects of phospholipid hepatoprotective agents in experimental Reye syndrome].A S Saratikov et al.Biulleten' eksperimental'noi biologii i meditsiny, 129(3), 337-339 (2000-04-25)
In vivo formation of the thiol conjugates of reactive metabolites of 4-ene VPA and its analog 4-pentenoic acid.K Kassahun et al.Drug metabolism and disposition: the biological fate of chemicals, 21(6), 1098-1106 (1993-11-01)
13C and 1H NMR study of the metabolic degradation of 4-pentenoate in different dog nephron segments.Y Boulanger et al.Magnetic resonance in medicine, 28(1), 137-144 (1992-11-01)
Brush border membrane proteins in experimental Fanconi's syndrome induced by 4-pentenoate and maleate.J F Pouliot et al.Canadian journal of physiology and pharmacology, 70(9), 1247-1253 (1992-09-01)
No participation of adenosine A1 receptor in acute nephrotoxicity by 4-pentenoic acid administration in dogs.K Miura et al.Japanese journal of pharmacology, 80(3), 223-228 (1999-08-26)
The incorporation and release of 12(S)-hydroxyeicosatetraenoic acid and its major metabolite, 8(S)-hydroxyhexadecatrienoic acid, from rabbit corneal lipids.J S Hurst et al.Experimental eye research, 59(1), 97-105 (1994-07-01)
Metabolism of 4-hydroxynonenal, a cytotoxic product of lipid peroxidation, in rat precision-cut liver slices.A Laurent et al.Toxicology letters, 114(1-3), 203-214 (2000-03-14)
Effect of silimarin, succinic acid, and their combination on bioenergetics of the brain in experimental encephalopathy.V A Khazanov et al.Bulletin of experimental biology and medicine, 144(6), 806-809 (2008-10-17)
Formation of poly(hydroxybutyrate-co-hydroxyvalerate) by Azotobacter vinelandii UWD.W J Page et al.Applied and environmental microbiology, 58(9), 2866-2873 (1992-09-01)
Fluorinated analogues as mechanistic probes in valproic acid hepatotoxicity: hepatic microvesicular steatosis and glutathione status.W Tang et al.Chemical research in toxicology, 8(5), 671-682 (1995-07-01)
[Effects of silymarin and its combination with succinic acid on brain bioenergetics in rats with experimental inhibition of beta-oxidation of fatty acids].A I Vengerovskiĭ et al.Eksperimental'naia i klinicheskaia farmakologiia, 70(2), 51-55 (2007-05-26)
Formulations of valproate alter valproate metabolism: a single oral dose kinetic study.Goyo Nagai et al.Therapeutic drug monitoring, 31(5), 592-596 (2009-08-26)
Total synthesis of (-)-talaumidin and (-)-galbelgin.Peng Xue et al.Journal of Asian natural products research, 11(3), 281-287 (2009-05-02)
[Therapeutic effect of hepatoprotectors in experimental Reye syndrome].A I Vengerovskiĭ et al.Eksperimental'naia i klinicheskaia farmakologiia, 63(5), 68-71 (2000-12-08)
Accumulation of polyhydroxyalkanoic acid containing large amounts of unsaturated monomers in Pseudomonas fluorescens BM07 utilizing saccharides and its inhibition by 2-bromooctanoic acid.H J Lee et al.Applied and environmental microbiology, 67(11), 4963-4974 (2001-10-27)
备注
Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1).
名称 | CAS号 |
---|

相关产品
相关资讯
问
热门标签
询 单
请 填 写 相 关 信 息
- 请填写产品名称!
- CAS号
- 请正确填写公司名称!
- 请正确填写联系人!
- 请正确填写联系电话!
- 请正确填写联系邮箱!
- 请描述您的问题!